6533b856fe1ef96bd12b1d4b

RESEARCH PRODUCT

Do we need better lipid tools for cardiovascular risk assessment ?

Kaspar BerneisRizzo Manfredi

subject

medicine.medical_specialtyCardiovascular diseases Dyslipidemia Lipoproteinsbusiness.industrymedicineGeneral MedicineIntensive care medicineRisk assessmentbusinesshttp://hdl.handle.net/10447/77623